Cluster Headaches

Chronic Cluster Headaches, Next Target For This Non-Hallucinogenic Psychedelic

Lobe Sciences (OTCQB: LOBEF), the psychedelics company performing drug R&D with sub-hallucinatory doses of psychedelics has signed a research agreement with headache medicine specialist Dr. Lauren R.

Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying

(Part three of a four-part series) Despite ongoing legal setbacks, psychedelics research has reemerged and it is proving that psilocybin reduces brain connections within the usual networks while amplifying links between less connected areas.